mobileMICROMEDEX gives physicians, pharmacists, and other healthcare professionals reliable clinical information to help support and confirm treatment decisions. Clinicians can trust the data i
Focuses primarily on the drugs used for treatment and symptom management for colorectal cancer.
Portable Drug Companion is a comprehensive, authoritative drug reference to chose from over 5,500 entries, with overdose management, Canadian drug names, OTC and herbal remedies. This "Mini-Suite" of
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy.
Medicine Products:(Date:12/3/2008)...enchmark data providing information by disease sta...s , , SAN FRANCISCO, Dec. 3 /PRNewswire-USN...or and effectiveness of their health and productiv... Benefits Institute (IBI) announced today the avai...oes IBI,s benchmarking offer the ability to access...
(Date:12/3/2008)...) treatment seems to improve cognitive functioning...fer from obstructive sleep apnea, according to the...at the University of California, San Diego. The st...of psychiatry at the UC San Diego School of Medici...he field of sleep disorders and sleep research in ...
(Date:12/3/2008)...ian television viewers will get,a chance to learn...ht when the,documentary "The Brain That Changes I...n network. Based on the best-selling book of the ...ntary traces the development of the,science of ne..., products and,customers of Posit Science Corpora...
(Date:12/3/2008)...rvice Reductions , , WASHINGTON, Dec. 3 /P...or Quality Respiratory Care (CQRC) -- an alliance ... manufacturers that care for nearly half of Medica...eparing for massive Medicare cuts to the program,s... , , The Medicare Part B home oxygen bene...
Breaking Medicine News(10 mins):Health News:Integrated Benefits Institute Announces Availability of 2007 IBI Benchmarking Data for Employers to Evaluate Effectiveness of their Health and Productivity Programs 2Health News:Treating sleep apnea in Alzheimer's patients helps cognition 2Health News:Treating sleep apnea in Alzheimer's patients helps cognition 3Health News:Posit Science Featured in Canadian Documentary on the Brain 2Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 2Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 3... the combination of chemotherapy with a new medica...ents.// In the study of close to 1,000 patients, ... in patients who received chemotherapy and the ora... study show 65 patients who received the combined ...
...ause of blindness for blacks and whites is not the... the leading cause of blindness for whites, while ...lindness for blacks. More than 50 percent of the w...ion because of macular degeneration. In contrast, ...
...ns undergo balloon angioplasty to clear blocked ar... again.// Now, a cancer drug may change the outcom...knowing he's doing everything he can to avoid a se...years ago, he had a quintuple bypass operation. . ...
...t study researchers offer new insights about stret...ng before exercising.// Specialists say stretching...nt research shows static stretching makes muscles ...ease the risk of injury. They say some likely caus...
Other Medicine News:(Date:12/1/2008)...d With ENB-0040 at Children,s Hospital, Health Sci... 1 Enobia Pharma, an emerging Cana...herapeutics for serious bone disorders, today anno...l program for hypophosphatasia was dosed. Enobia i...ith ENB-0040 for the treatment of this rare and of...
(Date:12/1/2008)...ire-FirstCall/ -- Genaera Corporation (Nasdaq: ... begun in study MSI-1436C-102 (Study 102), the mul...ne (MSI-1436) in overweight and obese type 2 diabe...tment of type 2 diabetes and obesity which works c...leptin pathways through the highly selective inhib...
(Date:12/1/2008)... -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX),...,human vaccines for diseases caused by HIV-1 (Hum...gents, announced today that the launch of its Phas...ve sites across North and South America.,These tr...nal Institutes of,Health (NIH), and the HIV Vacci...
(Date:11/30/2008).../ -- Abnormalities in auditory and language proces...trum disorder by using magnetoencephalography (MEG...ual meeting of the Radiological Society of North A...d the tiny magnetic fields associated with electri...vice chair of research in the Department of Radiol...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3SemBioSys eligible to proceed with Phase I II plant produced insulin trial after submission of IND 7709 1SemBioSys eligible to proceed with Phase I II plant produced insulin trial after submission of IND 7709 2SemBioSys eligible to proceed with Phase I II plant produced insulin trial after submission of IND 7709 3Intact Medical Corporations Intact 28R 29 Excise XL Receives 510 28K 29 Marketing Clearance from the FDA 7708 1Intact Medical Corporations Intact 28R 29 Excise XL Receives 510 28K 29 Marketing Clearance from the FDA 7708 2BioCryst to Present at UBS 2008 Global Life Sciences Conference 7703 1BioCryst to Present at UBS 2008 Global Life Sciences Conference 7703 2BioCryst to Present at UBS 2008 Global Life Sciences Conference 7703 3Althea Technologies Secures 2412 M Credit Line to Continue Facility Growth and Expansion 7701 1Althea Technologies Secures 2412 M Credit Line to Continue Facility Growth and Expansion 7701 2...E, Md., April 18, 2007--Due to water damage caused... to change the,location for the upcoming Antiviral...7 to discuss new drug application for,maraviroc 30...ld at,the FDA, Center for Drug Evaluation and Rese...0 Fishers Lane, in Rockville, MD, the,meeting has ...
...la., April 16, 2007 /PRNewswire/ -- Sirion Therape...al company, announced,today that it has received o...nistration (FDA) for its anti-viral therapy,ganci...tis. The,product is currently marketed by Laborato...(R). Sirion licensed the rights to,Virgan(R) for t...
Other Medicine Technology:FDA Announces Change of Location Notice for Upcoming Advisory,Committee Meeting 2Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2